Table 1. Characteristics of the 51 patients with advanced colorectal cancer treated with irinotecan, capecitabine, and celecoxib.
| Characteristics Median age (range) | Number 58 (32–78) | Percentage |
|---|---|---|
| Sex | ||
| Male | 31 | 61 |
| Female | 20 | 39 |
| Race | ||
| African-American | 16 | 31 |
| Caucasian | 35 | 69 |
| Performance status | ||
| 0 | 12 | 24 |
| 1 | 38 | 75 |
| 2 | 1 | 2 |
| Metastatic site | ||
| Liver | 45 | 88 |
| Lung | 21 | 41 |
| Peritoneum | 6 | 12 |
| Other | 29 | 57 |
| Number of metastatic sites | ||
| 1 | 18 | 35 |
| 2 | 20 | 39 |
| 3 | 9 | 18 |
| 4 | 4 | 8 |
| Site of primary disease | ||
| Colon | 40 | 78 |
| Rectum | 11 | 22 |
| Prior adjuvant therapy | ||
| Chemotherapy | 8 | 16 |
| Chemoradiotherapy | 6 | 12 |